CEO pay benchmark · $10B – $200B
Large-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at large-cap companies in the pharmaceutical preparations industry is $14,467,393. That is 40% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$14.5M
Typical range
$9.1M–$18.0M
Companies
13
Average pay ratio
5:1
Vs. full industry
+40%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Large-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 13 | 35 |
| Median CEO pay | $14,467,393 | $10,364,688 |
| Average CEO pay | $13,764,095 | $11,740,936 |
| Middle 50% range | $9.1M–$18.0M | $8.0M–$15.1M |
| Average pay ratio | 5:1 | 5:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Roivant Sciences Ltd.ROIV | Eric Venker | $24.4M | $26.2B |
| ABBOTT LABORATORIESABT | Robert B. Ford | $24.2M | $175.5B |
| MADRIGAL PHARMACEUTICALS, INC.MDGL | Bill Sibold | $19.2M | $12.0B |
| UNITED THERAPEUTICS CorpUTHR | Martine Rothblatt | $18.0M | $22.7B |
| CORCEPT THERAPEUTICS INCCORT | Joseph K. Belanoff | $15.3M | $12.9B |
| Alnylam Pharmaceuticals, Inc.ALNY | Yvonne L. Greenstreet | $14.9M | $31.6B |
| INSMED IncINSM | William H. Lewis | $14.5M | $23.8B |
| SanofiSNY | Paul Hudson | $10.8M | $54.5B |
| Axsome Therapeutics, Inc.AXSM | Herriot Tabuteau | $10.4M | $10.4B |
| VERTEX PHARMACEUTICALS INC / MAVRTX | Reshma Kewalramani | $9.1M | $130.7B |
Nearby peer groups